Table 3.
Treatment and outcome of 18 patients with acute antibody-mediated rejection
| Case | Treatment | Graft status/survival (mo) | Re-Tx/graft type | Patient status/survival (mo) |
| 1 | ST/IVIG/OKT3 | CHR/30.5 | None | Dead (liver failure)/30.5 |
| 2 | ST/IVIG/OKT3/Campath | CHR/13.5 | None | Dead (ruptured pseudo-aneurysm)/18.6 |
| 3 | ST/OKT3 | Functioning/75.9 | None | Alive/75.9 |
| 41 | ST/OKT3 | CHR/5.4 | Yes/MV | Dead (pneumonia)/43.0 |
| 5 | ST/OKT3 | Functioning/17.7 | None | Alive/17.7 |
| 6 | ST/OKT3 | Functioning/56.4 | None | Alive/56.4 |
| 7 | ST/OKT3/Campath | ACR/31.7 | None | Dead (pneumonia)/31.7 |
| 8 | ST/Campath | Functioning/30.3 | None | Dead (unknown)/30.3 |
| 9 | ST | CHR/35.4 | Yes/MV | Alive/55.4 |
| 101 | ST/OKT3 | ACR/13.2 | None | Dead (sepsis)/15.5 |
| 11 | ST | Functioning/52.6 | None | Alive/52.6 |
| 121 | ST/ATG | CHR/22.6 | None | Alive/22.6 |
| 13 | ST | AHR/2.7 | Yes/MV | Alive/76.4 |
| 14 | ST | Functioning/22.5 | None | Alive/22.5 |
| 15 | ST/OKT3 | CHR/4.8 | None | Dead (sepsis)/32.8 |
| 16 | ST | CHR/12.3 | None | Alive/46.2 |
| 172 | ST/OKT3 | CHR/12.6 | Yes/SB | Dead (GI bleeding)/13.3 |
| 183 | ST/OKT3 | Functioning/37.6 | Yes/MV | Alive/37.6 |
Type of transplant: SB: An isolated small bowel; MV: A full multivisceral graft.
1
Patients with repeat ABMR;
2
Patient with a history of ABMR after prior transplant;
3
Patient with prior transplant. ST: Steroids; IVIG: Intravenous immunoglobulin; ACR: Acute cellular rejection; CHR: Chronic rejection.